Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts

Journal of Molecular and Cellular Cardiology
T TatsumiHiroaki Matsubara

Abstract

The mechanism responsible for cardiac depression in septic shock remains unknown. The present study examined whether nitric oxide (NO) overproduced by inducible NO synthase (iNOS) can inhibit aerobic energy metabolism and impair the myocardial function in endotoxin-treated rat hearts. Lipopolysaccharide (LPS) significantly decreased systolic blood pressure (BP) to 44% of control during the 48 h treatment. Hearts from control and LPS-treated rats were perfused in a Langendorff apparatus. After LPS injection, left ventricular (LV) developed pressure (LVDP) was significantly depressed, plasma NO2-/NO3- (NO(x)) concentration was markedly increased, and myocardial adenosine 5'-triphosphate (ATP), creatine phosphate (CrP), and the ratio of ATP/adenosine 5'-diphosphate were progressively decreased with time. Immunological examination showed a significant expression of iNOS protein in the LPS-treated myocytes. Aminoguanidine, an inhibitor of iNOS, significantly attenuated these LPS-induced functional and metabolic changes. Myocardial cyclic guanosine 3',5'-monophosphate (cGMP) content was significantly increased after LPS injection. Methylene blue, an inhibitor of soluble guanylate cyclase, blunted this increase in cGMP and significant...Continue Reading

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C RamaciottiS Winegrad
Sep 21, 1991·Lancet·J Cohen, M P Glauser
Jan 1, 1991·The American Journal of Physiology·R S HotchkissJ J Ackerman
Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Apr 1, 1988·JAMA : the Journal of the American Medical Association·E C RackowM H Weil
Sep 1, 1970·Journal of Molecular and Cellular Cardiology·S GudbjarnasonK G Ravens
Sep 1, 1969·The Biochemical Journal·D Shepherd, P B Garland
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J L BalligandT Michel
Nov 4, 1993·The New England Journal of Medicine·R G KilbournS S Gross
Apr 21, 1994·The New England Journal of Medicine·L G Lange, G F Schreiner
May 1, 1994·Circulation Research·A M ShahE G Lakatta
May 20, 1993·The New England Journal of Medicine·J E Parrillo
Mar 21, 1998·Journal of the American College of Cardiology·T TatsumiM Nakagawa
May 13, 1999·Biochimica Et Biophysica Acta·M A Titheradge
Mar 13, 2002·Critical Care Medicine·Elliott D CrouserDouglas R Pfeiffer
Nov 8, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·David BrealeyMervyn Singer
Jan 22, 2004·Journal of Molecular and Cellular Cardiology·J A WattsS S Brar

❮ Previous
Next ❯

Citations

Oct 13, 2006·Malaria Journal·Ian A ClarkWilliam B Cowden
Nov 16, 2013·International Journal of Molecular Sciences·Martin L Pall
Apr 7, 2010·Wiener medizinische Wochenschrift·Martina Wendel, Axel R Heller
Apr 22, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Vanessa F MerinoMichael Bader
Jan 30, 2010·Nitric Oxide : Biology and Chemistry·Nicole P JuffermansA B Johan Groeneveld
Jun 23, 2009·European Journal of Pharmacology·Kwanjit SompamitVeerapol Kukongviriyapan
Nov 13, 2007·Journal of Molecular and Cellular Cardiology·Jianli NiuPappachan E Kolattukudy
Mar 18, 2008·Travel Medicine and Infectious Disease·Ian A ClarkWilliam B Cowden
Mar 19, 2013·European Journal of Clinical Investigation·Victor JegerJukka Takala
Mar 25, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yulin LiaoMasafumi Kitakaze
Jan 6, 2015·Antioxidants & Redox Signaling·Anne D Cherry, Claude A Piantadosi
Jul 6, 2016·Neuroscience and Biobehavioral Reviews·Giselli ScainiJoão Quevedo
Feb 11, 2018·Environmental Toxicology·Heng-Dao LinSsu-Ching Chen
Apr 17, 2012·British Journal of Hospital Medicine·Tom AdamsDaniel Martin
Jul 12, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Prabhakara Reddy NagareddyKathleen M MacLeod
Aug 6, 2005·American Journal of Respiratory and Critical Care Medicine·Kieran P O'DeaMasao Takata
Jul 20, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Hai-Yan PanJian-Hua Zhu
Dec 21, 2016·The Journal of Physiological Sciences : JPS·Huiling JinYoshihiro Ishikawa
Jul 22, 2019·International Journal of Molecular Sciences·Andrew J Lautz, Basilia Zingarelli
Jan 17, 2021·International Journal of Molecular Sciences·Birte WeberMiriam Kalbitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.